Induction of an osteoarthritis‐like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice
Open Access
- 29 September 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (10), 3132-3144
- https://doi.org/10.1002/art.23946
Abstract
Objective To determine whether Smurf2, an E3 ubiquitin ligase known to inhibit transforming growth factor β (TGFβ) signaling, is expressed in human osteoarthritic (OA) cartilage and can initiate OA in mice. Methods Human OA cartilage was obtained from patients undergoing knee arthroplasty. Samples were graded histologically using the Mankin scale and were examined immunohistochemically for Smurf2 expression. A transgene driven by the collagen 2α1 promoter was used to overexpress Smurf2 in mice. Smurf2 overexpression in mouse sternal chondrocytes was confirmed by reverse transcription–polymerase chain reaction and Western blotting. Changes in articular cartilage area, chondrocyte number, and chondrocyte diameter were assessed histomorphometrically using OsteoMeasure software. Alterations in type X collagen and matrix metalloproteinase 13 (MMP‐13) in articular chondrocytes were examined by in situ hybridization and immunohistochemistry, respectively. Joint bone phenotypes were evaluated by microfocal computed tomography. The effects of Smurf2 overexpression on TGFβ signaling were examined using a luciferase‐based reporter and immunoprecipitation/Western blotting. Results Human OA cartilage strongly expressed Smurf2 as compared with nonarthritic human cartilage. By 8 months of age, Smurf2‐transgenic mice exhibited decreased articular cartilage area, fibrillation, clefting, eburnation, subchondral sclerosis, and osteophytes. Increased expression of type X collagen and MMP‐13 were also detected in articular cartilage from transgenic mice. Transgenic sternal chondrocytes showed reduced TGFβ signaling as well as decreased expression and increased ubiquitination of pSmad3. Conclusion Smurf2 is up‐regulated during OA in humans, and Smurf2‐transgenic mice spontaneously develop an OA‐like phenotype that correlates with decreased TGFβ signaling and increased pSmad3 degradation. Overall, these results suggest a role of Smurf2 in the pathogenesis of OA.Keywords
This publication has 47 references indexed in Scilit:
- Generation of a transgenic mouse model with chondrocyte‐specific and tamoxifen‐inducible expression of Cre recombinaseGenesis, 2007
- The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritisFrontiers in Bioscience-Landmark, 2006
- Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient miceOsteoarthritis and Cartilage, 2005
- Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1 : a possible explanation for the changes in matrix synthesis during osteoarthritisAnnals Of The Rheumatic Diseases, 2004
- Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β SignalingJournal of Biological Chemistry, 2000
- The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of ChondrogenesisThe Journal of Experimental Medicine, 2000
- Activation of fibrillar collagen synthesis and phenotypic modulation of chondrocytes in early human osteoarthritic cartilage lesionsOsteoarthritis and Cartilage, 1997
- Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone.Genes & Development, 1995
- Type X collagen expression in osteoarthritic and rheumatoid articular cartilageVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Developmental regulation for collagen II gene expression in transgenic miceTeratology, 1991